Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States

scientific article

Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/QAI.0B013E31821AE418
P932PMC publication ID3431159
P698PubMed publication ID21471818

P50authorKathleen M. WeberQ112651762
Mardge H. CohenQ112651887
Phyllis C TienQ112652034
Elizabeth T GolubQ112652360
Audrey L. FrenchQ121210945
P2093author name stringAnjali Sharma
Marshall J Glesby
William Meyer
Daniel Merenstein
Denis Agniel
Oluwatoyin M Adeyemi
Maria C Villacres
P2860cites workHigh prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patientsQ43157193
Efavirenz and bone health.Q46006592
High frequency of vitamin D deficiency in ambulatory HIV-Positive patientsQ46183566
Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortalityQ46523052
Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United StatesQ46547776
Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective studyQ46549314
Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy.Q51678383
Deficiency of 25-hydroxyvitamin D in male HIV-positive patients: A descriptive cross-sectional studyQ60291323
Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general populationQ64129102
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney diseaseQ79337877
Severe vitamin D deficiency diagnosed after introduction of antiretroviral therapy including efavirenz in a patient living at latitude 59 degrees NQ80217296
Relationship between vitamin D status, parathyroid hormone levels and bone mineral density in patients with chronic kidney disease stages 3 and 4Q80501439
The Women's Interagency HIV Study. WIHS Collaborative Study GroupQ95805016
Update in vitamin DQ22306211
Vitamin d, adiposity, and calcified atherosclerotic plaque in african-americansQ24621603
Vitamin D deficiencyQ27860616
Active serum vitamin D levels are inversely correlated with coronary calcificationQ28250542
Vitamin D deficiency: a worldwide problem with health consequences.Q30368744
Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination SurveyQ31115409
Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortalityQ33526366
Vitamin D, race, and cardiovascular mortality: findings from a national US sampleQ33594288
Decreased bioavailability of vitamin D in obesityQ33916095
The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the benchQ34045522
The noncalciotropic actions of vitamin D: recent clinical developmentsQ34532994
Intakes of calcium and vitamin D and breast cancer risk in womenQ34579813
Vitamin D deficiency and risk of cardiovascular diseaseQ34586829
Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004.Q34967426
25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective studyQ37035497
Frequency of leisure-time physical activity and serum 25-hydroxyvitamin D levels in the US population: results from the Third National Health and Nutrition Examination SurveyQ37305912
The Rapidly Evolving Research on Vitamin D Among HIV-Infected PopulationsQ37838799
Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994.Q39606361
Vitamin D status in adolescents and young adults with HIV infectionQ39754515
Do we still need a cohort study of women with HIV infection?Q40866620
Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D.Q43048034
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectHIVQ15787
vitamin B12 deficiencyQ3234995
vitamin D deficiencyQ4138762
P304page(s)197-204
P577publication date2011-07-01
P1433published inJournal of Acquired Immune Deficiency SyndromesQ6294722
P1476titleVitamin D deficiency in HIV-infected and HIV-uninfected women in the United States
P478volume57

Reverse relations

cites work (P2860)
Q3407689225-Hydroxyvitamin D insufficiency and deficiency is associated with HIV disease progression and virological failure post-antiretroviral therapy initiation in diverse multinational settings
Q36060389Association among vitamin D, oral candidiasis, and calprotectinemia in HIV.
Q38095828Bone health and human immunodeficiency virus infection
Q31124706Bone turnover and bone mineral density in HIV-1 infected Chinese taking highly active antiretroviral therapy -a prospective observational study
Q35154069Change in vitamin d levels occurs early after antiretroviral therapy initiation and depends on treatment regimen in resource-limited settings
Q36074219Circulating vitamin D correlates with serum antimüllerian hormone levels in late-reproductive-aged women: Women's Interagency HIV Study
Q54224147Continued Interest and Controversy: Vitamin D in HIV.
Q36736469Cross-sectional study of vitamin D levels, immunologic and virologic outcomes in HIV-infected adults.
Q41644519Effect of a monthly dose of calcidiol in improving vitamin D deficiency and secondary hyperparathyroidism in HIV-infected patients
Q39673591High prevalence of vitamin D deficiency in HIV-infected adults: what are the future research questions?
Q46543775Higher vitamin D levels in HIV-infected out-patients on treatment with boosted protease inhibitor monotherapy
Q36177899Hyperparathyroidism and complications associated with vitamin D deficiency in HIV-infected adults in New York City, New York.
Q36381307Interventions to address chronic disease and HIV: strategies to promote exercise and nutrition among HIV-infected individuals.
Q40197765Is serum 25-hydroxyvitamin D associated with depressive symptoms and suicidal ideation in Korean adults?
Q89695724Low maternal vitamin D is associated with increased risk of congenital and peri/postnatal transmission of Cytomegalovirus in women with HIV
Q35706037Low vitamin D status among pregnant Latin American and Caribbean women with HIV Infection
Q37153745Number of Primary Care Visits Associated with Screening for Cervical Dysplasia among Women with HIV Infection in Harris County, Texas, United States of America
Q37379906Potential mechanisms for racial and ethnic differences in antimüllerian hormone and ovarian reserve
Q37156878Prevalence and Factors Associated with Vitamin D Deficiency and Hyperparathyroidism in HIV-Infected Patients Treated in Barcelona.
Q40563423Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: A prospective cohort study
Q40680683Prevalence of hypovitaminosis D and its association with oral lesions in HIV-infected Brazilian adults.
Q42229887Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected persons
Q38836871Protecting bone in long-term HIV positive patients receiving antiretrovirals
Q38450420Risk factors associated with hypovitaminosis D in HIV/aids-infected adults.
Q28538127Risk factors for vitamin D deficiency among HIV-infected and uninfected injection drug users
Q35510622Risk factors for vitamin D deficiency among veterans with and without HIV infection
Q37111446Short communication: High prevalence of vitamin D deficiency in HIV-infected and HIV-uninfected pregnant women
Q34404878Substantial effect of efavirenz monotherapy on bilirubin levels in healthy volunteers
Q59352745The impact of Middle Eastern Origin, HIV, HCV, and HIV/HCV co-infection in the development of hypovitaminosis D in adults
Q38005045Therapeutic options for low bone mineral density in HIV-infected subjects
Q41659730Ultraviolet index and location are important determinants of vitamin D status in people with human immunodeficiency virus
Q40517679Vitamin D Deficiency and Metabolism in HIV-Infected and HIV-Uninfected Men in the Multicenter AIDS Cohort Study
Q36447199Vitamin D Levels, Natural H1N1 Infection and Response to H1N1 Vaccine among HIV-Infected Individuals
Q39026377Vitamin D and Infectious Diseases: Simple Bystander or Contributing Factor?
Q36816930Vitamin D and bone loss in HIV
Q36899859Vitamin D and insulin resistance in non-diabetic women's interagency HIV study participants
Q36408936Vitamin D deficiency and its association with low bone mineral density, HIV-related factors, hospitalization, and death in a predominantly black HIV-infected cohort
Q54254278Vitamin D deficiency and periodontal clinical attachment loss in HIV-seropositive women: A secondary analysis conducted in the Women's Interagency HIV Study (WIHS).
Q37155210Vitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users
Q42939810Vitamin D deficiency in HIV-infected and -uninfected women in the United States
Q33615509Vitamin D insufficiency and subclinical atherosclerosis in non-diabetic males living with HIV
Q37518789Vitamin D insufficiency may impair CD4 recovery among Women's Interagency HIV Study participants with advanced disease on HAART.
Q35245597Vitamin D status and its association with morbidity including wasting and opportunistic illnesses in HIV-infected women in Tanzania
Q37625118Vitamin D status of human immunodeficiency virus-positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: multi-site study
Q33603196Vitamin D, bone, and HIV infection.

Search more.